BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: NZ$0.02 M
• Last 3 months FTD volume: NZ$0.58 M
• Last 12 months FTD volume: NZ$4.51 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	NZ$0.92 M	NZ$16.71 M	🇺🇸 USA
Sarepta Therapeutics SRPT	NZ$2.3 M	NZ$22.38 M	🇺🇸 USA
NanoViricides NNVC	NZ$1.96 M	NZ$6.74 M	🇺🇸 USA
Novavax NVAX	NZ$15.95 M	NZ$65.06 M	🇺🇸 USA
Gilead Sciences GILD	NZ$60.15 M	NZ$0.26 B	🇺🇸 USA
Celldex Therapeutics CLDX	NZ$7.65 M	NZ$11.96 M	🇺🇸 USA
GlaxoSmithKline GSK	NZ$72.01 M	NZ$0.40 B	🇬🇧 UK
Emergent BioSolutions EBS	NZ$1.89 M	NZ$4.32 M	🇺🇸 USA
Cel-Sci CVM	N/A	NZ$0.94 M	🇺🇸 USA